Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.459 SEK | -5.36% | -0.22% | -12.33% |
04-16 | Mendus AB Announces Board Changes | CI |
03-27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
45.04M | - | - | - | - | - | |
48.16B | - | |||||
41.73B | ||||||
41.03B | ||||||
28.77B | ||||||
25.59B |
- Stock Market
- Equities
- IMMU Stock
- Charts Mendus AB
- Sector Chart